Status:
COMPLETED
Effects of Antipsychotic Medications on Energy Intake and Expenditure
Lead Sponsor:
Washington University School of Medicine
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-80 years
Brief Summary
Aim 1: To evaluate the effect of antipsychotic treatment group on Activity Energy Expenditure. The project hypothesizes that subjects treated with olanzapine will demonstrate a greater decrease in AEE...
Detailed Description
The overall purpose of this research is to determine how two commonly prescribed antipsychotic medications, olanzapine (Zyprexa) and ziprasidone (Geodon), affect weight gain through increasing appetit...
Eligibility Criteria
Inclusion
- non-diabetic
- schizophrenic or schizoaffective
- currently prescribed olanzapine or ziprasidone
- 18-80 y.o.
Exclusion
- \<18 or \>80 years of age
- diabetic
- not schizophrenic or schizoaffective
- not currently prescribed olanzapine or ziprasidone
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00836251
Start Date
April 1 2006
End Date
June 1 2008
Last Update
March 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 53110